Skip to main content

ALC · Alcon Inc · Webcasts, Transcripts & Audio

Track ALC — free
$74.12 +2.29 (+3.19%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$35.61B
Shares
480.40M
Volume · Nov 13 2.79M Avg daily vol (3M) 1.82M

Alcon Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Alcon Inc (ALC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-11
Alcon Inc (ALC) Q3 2026 Earnings Call Transcript
Positive tone Equipment momentum and rollout Innovation and product launches Market growth and premiumization
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-11
Alcon Inc (ALC) Q2 2026 Earnings Call Transcript
Positive tone U.S. cataract market dynamics Implantables / IOL portfolio Unity VCS surgical platform
Revenue
$2.82B
▲ 8.7% YoY
Diluted EPS
$0.00
▼ 100% YoY
Gross margin
59.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Alcon Inc (ALC) Q1 2026 Earnings Call Transcript
Positive tone New product momentum Implantables / IOL share gains China IOL and VBP
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Alcon Inc (ALC) Q4 2025 Earnings Call Transcript
Positive tone IOL innovation pipeline China market dynamics Vision Care reusable contact lenses
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Alcon Inc (ALC) Q3 2025 Earnings Call Transcript
Positive tone Implantables / PanOptix Pro Ocular health (Systane, Tryptyr) Refractive / WaveLight Plus
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-20
Alcon Inc (ALC) Q2 2025 Earnings Call Transcript
Positive tone Long-term outlook and guidance Surgical market softness M&A and business development
Revenue
$2.60B
▲ 4% YoY
Diluted EPS
$0.35
▼ 22.2% YoY
Gross margin
53.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Alcon Inc (ALC) Q1 2025 Earnings Call Transcript
Positive tone Tariffs and trade policy Unity VCS launch Implantables / PanOptix Pro
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Alcon Inc (ALC) Q4 2024 Earnings Call Transcript
Positive tone Competitive pricing pressure in contact lenses Surgical pipeline (UNITY VCS, PanOptix Pro) Ocular health and SYSTANE
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Alcon Inc (ALC) Q3 2024 Earnings Call Transcript
Confident tone Ocular health / Systane Surgical implantables / IOLs Contact lens business
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-21
Alcon Inc (ALC) Q2 2024 Earnings Call Transcript
Confident tone Surgical / Unity Phaco platform China OcuMension partnership Contact Lenses innovation and share gains
Revenue
$2.50B
▲ 3.1% YoY
Diluted EPS
$0.45
▲ 32.4% YoY
Gross margin
55.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Alcon Inc (ALC) Q1 2024 Earnings Call Transcript
Confident tone Contact lens growth and share gains Margin outlook and tariffs Ocular Health and pharmaceuticals
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Alcon Inc (ALC) Q4 2023 Earnings Call Transcript
Confident tone Contact Lens Innovation China VBP Tender Ocular Health / Dry Eye (AR-15512)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-15
Alcon Inc (ALC) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-16
Alcon Inc (ALC) Q2 2023 Earnings Call Transcript
Revenue
$2.42B
▲ 9.2% YoY
Diluted EPS
$0.34
▲ 13.3% YoY
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Alcon Inc (ALC) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Alcon Inc (ALC) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-16
Alcon Inc (ALC) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Alcon Inc (ALC) Q2 2022 Earnings Call Transcript
Revenue
$2.22B
▲ 5.1% YoY
Diluted EPS
$0.30
▼ 3.2% YoY
Gross margin
54.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Alcon Inc (ALC) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-16
Alcon Inc (ALC) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Alcon Inc (ALC) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-18
Alcon Inc (ALC) Q2 2021 Earnings Call Transcript
Revenue
$2.11B
▲ 73.8% YoY
Diluted EPS
$0.31
Gross margin
57.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Alcon Inc (ALC) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Alcon Inc (ALC) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-11
Alcon Inc (ALC) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-19
Alcon Inc (ALC) Q2 2020 Earnings Call Transcript
Revenue
$1.21B
▼ 36.2% YoY
Diluted EPS
$-0.86
Gross margin
28.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-13
Alcon Inc (ALC) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 webcasts
Key facts CIK 1167379 CUSIP H01301128 13F (30d) 527 filings 453 filers Visit website Investor relations